Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex in Robotic Radical Cystectomy
NCT02454504Completed
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by IRCCS Regina Elena National Cancer Institute. Primary endpoint: Average score obtained on awakening according to specific test at 16 months. Started Mar 2015; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02454504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02454504.